Solid pseudopapillary neoplasm (SPN) is a rare, low malignant potential epithelial tumor of the pancreas, comprising 1-3% of all pancreatic tumors. Shows a striking sex and age predilection: 85-95% of patients are young women (mean age 20-30). The tumor is large (mean 6-10 cm), well-encapsulated, and solid-cystic in nature; cystic areas result from intratumoral hemorrhagic degeneration and necrosis. Histologically characterized by pseudopapillary structures (tumor cells arranged around fibrovascular stroma). Cell of origin is debated but thought to derive from acinar or neuroendocrine progenitor cells. Surgical resection is curative with 5-year survival exceeding 95%; metastasis rate is only 10-15%. Even cases showing malignant behavior have favorable prognosis.
Age Range
15-35
Peak Age
25
Gender
Female predominant
Prevalence
Rare
Although the pathogenesis of SPN is not fully elucidated, activation of the beta-catenin/Wnt signaling pathway has been demonstrated in nearly all cases (CTNNB1 gene mutation >95%). This mutation enables nuclear accumulation of beta-catenin and increases cell proliferation — nuclear beta-catenin positivity on immunohistochemistry is a diagnostic marker. The striking female predilection is explained by progesterone receptor expression — tumor cells are progesterone receptor positive and sensitive to hormonal influences. As the tumor grows, hemorrhagic necrosis and cystic degeneration develop in central areas with inadequate blood supply. This intratumoral hemorrhage forms the basis of T1 hyperintensity (methemoglobin) and fluid-debris levels on imaging. Pseudopapillary structures form from loose arrangement of tumor cells around fibrovascular cores and desquamation of central cells — unlike true papillary structures, a regular stromal core is lacking. The capsule is usually intact and local invasion is rare; this feature is the morphological reflection of low malignant potential.
High-signal areas within the tumor due to hemorrhage on T1-weighted fat-suppressed MR images. This finding is the signature finding of SPN — generally not seen in pancreatic cystic neoplasms (serous, mucinous, IPMN). Due to the paramagnetic T1-shortening effect of methemoglobin.
High-signal areas within the tumor on T1-weighted images — intratumoral hemorrhage (methemoglobin). This T1 hyperintensity is the most characteristic MRI finding of SPN and is not seen in other pancreatic cystic neoplasms (serous, mucinous, IPMN). Distribution of hemorrhagic areas is heterogeneous — very bright in some regions, intermediate signal in others. Signal is preserved on fat-suppressed T1 (blood product, not fat).
Report Sentence
A large encapsulated mass in the pancreas containing hyperintense areas on T1-weighted images due to intratumoral hemorrhage is identified, consistent with solid pseudopapillary neoplasm.
Encapsulated mass showing heterogeneous signal on T2-weighted images. Solid components show intermediate-low signal, cystic/necrotic areas show high signal, areas of acute hemorrhage show low signal. This 'mixed signal' pattern reflects the solid-cystic-hemorrhagic composition of SPN. Capsule is seen as a thin low-signal band on T2.
Report Sentence
The mass shows heterogeneous signal on T2-weighted images, reflecting coexistence of solid, cystic, and hemorrhagic components.
Well-defined encapsulated, heterogeneous solid-cystic mass. Solid components show mild-moderate enhancement in arterial phase with progressive enhancement increase in delayed phase. Cystic/necrotic areas do not enhance and remain at low density. Capsule is seen as a thin, enhancing band. Coarse calcifications can be seen in ~30% of cases — peripheral or central location.
Report Sentence
A well-defined encapsulated, heterogeneously enhancing solid-cystic mass in the pancreas is identified, showing a progressive enhancement pattern.
Well-defined, encapsulated, large mass with mixed echogenicity. Solid areas are hypoechoic-isoechoic, cystic areas are anechoic, and hemorrhagic areas show variable echogenicity (with hyperechoic debris). Capsule is seen as a hyperechoic thin band. Intratumoral fluid-debris levels (changing with patient position) may be visible. Doppler shows vascular flow in solid components.
Report Sentence
A large, well-defined encapsulated mass with mixed echogenicity in the pancreas is identified; further imaging (MRI) for SPN is recommended given its solid-cystic architecture.
Hyperintense signal in solid components on DWI with low ADC values on ADC map. Cystic/necrotic areas show variable signal on DWI. Diffusion restriction reflects cellularity of solid tumoral tissue. DWI adds value in solid-cystic differentiation and improves detection of peripheral solid components.
Report Sentence
Diffusion restriction is identified in the solid components of the mass on DWI.
Criteria
Both solid and cystic components prominent, hemorrhage and necrosis present, well-encapsulated. Vast majority of all SPNs (85-90%).
Distinct Features
Typical imaging findings: T1 hemorrhage, heterogeneous enhancement, capsule, fluid-debris level. Diagnosis is usually confident combined with young female demographics.
Criteria
Solid component predominant (>70%), minimal cystic area. Usually seen in small tumors (<3-4 cm) — not yet sufficient hemorrhagic necrosis.
Distinct Features
May show homogeneous enhancement — can be confused with PanNET. However, SPN's progressive enhancement pattern (increasing from arterial to delayed phase) distinguishes from PanNET's flash arterial enhancement. T1 hemorrhage signal may still be present.
Criteria
Capsular invasion, vascular invasion, peripancreatic fat infiltration, or distant metastasis (10-15% of cases). Histologically perineural invasion, angioinvasion.
Distinct Features
Disruption of capsular continuity, irregular margins, extension into surrounding tissues, liver metastasis. Even in malignant SPN, post-surgical prognosis is good (5-year survival >80%). Liver metastases may be solid-cystic and encapsulated similar to primary tumor.
Distinguishing Feature
PanNET shows intense hypervascular enhancement (flash enhancement) in arterial phase while SPN shows progressive enhancement pattern. T1 hemorrhage hyperintensity is very rare in PanNET. PanNET shows no age/sex predilection while SPN is specific to young women. PanNET shows intense uptake on Ga-68 DOTATATE PET-CT, SPN does not.
Distinguishing Feature
MCN is macrocystic (few large cysts filled with mucinous fluid) while SPN is solid-cystic (hemorrhagic degeneration). T1 hemorrhage is not seen in MCN, cyst fluid has high CEA and mucin positive. MCN in women aged 40-50, SPN in young women aged 20-30. MCN shows peripheral calcification, SPN shows central/heterogeneous calcification.
Distinguishing Feature
PDAC is hypovascular, infiltrative, with irregular margins while SPN is well-encapsulated with heterogeneous enhancement. Ductal obstruction and upstream atrophy in PDAC are absent in SPN. PDAC occurs at advanced age (60-80), SPN in young women (20-30). PDAC does not show hemorrhage on T1. Demographic difference alone is a strong distinguishing feature.
Urgency
routineManagement
surgicalBiopsy
Not NeededFollow-up
specialist-referralSPN is a tumor with low malignant potential and surgical resection is curative. Diagnosis is usually confidently made with typical imaging findings in a young woman, and preoperative biopsy is mostly not required. Surgery: distal pancreatectomy (tail) or Whipple (head) depending on location; enucleation may be considered if capsule is intact. Post-surgical 5-year survival exceeds 95% — excellent prognosis. Even in metastatic disease (liver metastases), surgical resection is recommended and survival remains good (>80% 5-year). Neoadjuvant/adjuvant chemotherapy is generally not needed. Long-term follow-up after surgery is recommended as late recurrence has been reported albeit rarely.
SPN has low-grade malignant potential and surgical resection is curative. 5-year survival is excellent after complete resection in 95% of patients. Local invasion and liver metastasis are rare but can occur. SPN must be considered in the differential diagnosis when a large pancreatic mass is detected in young women.